Agricultural Biotechnology Research Center, Academia Sinica, Taipei 11529, Taiwan.
Molecular Medicine Research Center, Chang Gung University, Taoyuan 33302, Taiwan; Department of Otolaryngology-Head & Neck Surgery, Chang Gung Memorial Hospital, Linkou, Taoyuan 33305, Taiwan.
Mol Cell Proteomics. 2019 Oct;18(10):1939-1949. doi: 10.1074/mcp.RA119.001654. Epub 2019 Jul 17.
Patients with oral cavity squamous cell carcinoma (OSCC) are frequently first diagnosed at an advanced stage, leading to poor prognosis and high mortality rates. Early detection of OSCC using body fluid-accessible biomarkers may improve the prognosis and survival rate of OSCC patients. As tumor interstitial fluid is a proximal fluid enriched with cancer-related proteins, it is a useful reservoir suitable for the discovery of cancer biomarkers and dysregulated biological pathways in tumor microenvironments. Thus, paired interstitial fluids of tumor (TIF) and adjacent noncancerous (NIF) tissues from 10 OSCC patients were harvested and analyzed using one-dimensional gel electrophoresis coupled with liquid chromatography-tandem mass spectrometry (GeLC-MS/MS). Using label-free spectral counting-based quantification, 113 proteins were found to be up-regulated in the TIFs compared with the NIFs. The gene set enrichment analysis (GSEA) revealed that the differentially expressed TIF proteins were highly associated with aminoacyl tRNA biosynthesis pathway. The elevated levels of 4 proteins (IARS, KARS, WARS, and YARS) involved in the aminoacyl tRNA biosynthesis were verified in the OSCC tissues with immunohistochemistry (IHC). In addition, nidogen-1 (NID1) was selected for verification as an OSCC biomarker. Salivary level of NID1 in OSCC patients ( = 48) was significantly higher than that in the healthy individuals ( = 51) and subjects with oral potentially malignant disorder (OPMD; = 53). IHC analysis showed that NID1 level in OSCC tissues was increased compared with adjacent noncancerous epithelium ( = 222). Importantly, the elevated NID1 level was correlated with the advanced stages of OSCC, as well as the poor survival of OSCC patients. Collectively, the results suggested that TIF analysis facilitates understanding of the OSCC microenvironment and that salivary NID1 may be a useful biomarker for OSCC.
口腔鳞状细胞癌 (OSCC) 患者通常在晚期被首次诊断,导致预后不良和高死亡率。使用体液可及的生物标志物早期检测 OSCC 可能改善 OSCC 患者的预后和生存率。由于肿瘤间质液富含与癌症相关的蛋白质,因此它是一种有用的储库,适合于发现肿瘤微环境中的癌症生物标志物和失调的生物学途径。因此,从 10 名 OSCC 患者中采集配对的肿瘤间质液 (TIF) 和相邻非癌组织 (NIF) 并使用一维凝胶电泳结合液相色谱-串联质谱 (GeLC-MS/MS) 进行分析。使用基于无标签谱计数的定量方法,发现与 NIF 相比,TIF 中 113 种蛋白质上调。基因集富集分析 (GSEA) 表明,差异表达的 TIF 蛋白与氨酰 tRNA 生物合成途径高度相关。免疫组织化学 (IHC) 验证了 OSCC 组织中涉及氨酰 tRNA 生物合成的 4 种蛋白质 (IARS、KARS、WARS 和 YARS) 水平升高。此外,选择了连接蛋白 1 (NID1) 作为 OSCC 生物标志物进行验证。与健康个体 ( = 51) 和口腔潜在恶性疾病个体 ( = 53) 相比,OSCC 患者的唾液 NID1 水平明显更高 ( = 48)。IHC 分析表明,与相邻的非癌上皮相比,OSCC 组织中 NID1 水平升高 ( = 222)。重要的是,升高的 NID1 水平与 OSCC 的晚期阶段以及 OSCC 患者的不良生存相关。总之,这些结果表明 TIF 分析有助于理解 OSCC 微环境,唾液 NID1 可能是 OSCC 的有用生物标志物。